Publicado 6 números por año
ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472
Indexed in
Human Leukemia-derived Dendritic Cells: Ex-vivo Development of Specific Antileukemic Cytotoxicity
SINOPSIS
The human myeloid leukemias are a diverse group of disorders characterized by massive clonal expansion of myeloid cells showing variable degrees of differentiation block. Leukemic dendritic cells were generated in culture from chronic myelogenous leukemia (CML). These were used to stimulate autologous T cells to develop leukemia-specific cytotoxicity. Available data suggest that the cells responsible for the cytolytic activity are at least in part CD8+ and HLA restricted in their function. Additional data suggest that some anti-CML cellular activity may be Fas mediated. T-cell receptor studies provide evidence for an oligoclonal response implying a recognition of a limited number of antigens. We have used culture techniques similar to those used for CML to study the ability of AML cells to differentiate toward dendritic cells. Four of five patients have shown acute leukemia-derived dendritic cells. This work offers an avenue for the development of novel strategies for the control of human myeloid leukemias.
-
Waclavicek M., Berer A., Oehler L., Stöckl J., Schloegl E., Majdic O., Knapp W., Calcium ionophore: a single reagent for the differentiation of primary human acute myelogenous leukaemia cells towards dendritic cells, British Journal of Haematology, 114, 2, 2001. Crossref
-
Bruserud Oystein, Ulvestad Elling, Effects of gamma-Irradiation on Acute Myelogenous Leukemia Blasts: In Vitro Studies of Proliferation, Constitutive Cytokine Secretion, and Accessory Cell Function During T Cell Activation, Journal of Hematotherapy & Stem Cell Research, 8, 4, 1999. Crossref
-
Li Li, Reinhardt Peter, Schmitt Anita, Barth Thomas F. E., Greiner Jochen, Ringhoffer Mark, Döhner Hartmut, Wiesneth Markus, Schmitt Michael, Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens, Cancer Immunology, Immunotherapy, 54, 7, 2005. Crossref
-
Chen Xiao, Regn Sybille, Raffegerst Silke, Kolb Hans-Jochem, Roskrow Marie, Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia, British Journal of Haematology, 111, 2, 2000. Crossref
-
Dietz Allan B., Bulur Peggy A., Erickson Michele R., Wettstein Peter J., Litzow Mark R., Wyatt William A., Dewald Gordon W., Tefferi Ayelew, Pankratz V. Shane, Vuk-Pavlovic Stanimir, Optimizing Preparation of Normal Dendritic Cells andbcr-abl+Mature Dendritic Cells Derived from Immunomagnetically Purified CD14+Cells, Journal of Hematotherapy & Stem Cell Research, 9, 1, 2000. Crossref
-
Charbonnier Aude, Gaugler Béatrice, Sainty Danielle, Lafage-Pochitaloff Marina, Olive Daniel, Human acute myeloblastic leukemia cells differentiatein vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias, European Journal of Immunology, 29, 8, 1999. Crossref
-
Mutis Tuna, Goulmy Els, Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies, Seminars in Hematology, 39, 1, 2002. Crossref
-
Chen Xiao, Regn Sybille, Raffegerst Silke, Kolb Hans-Jochem, Roskrow Marie, Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia, British Journal of Haematology, 111, 2, 2000. Crossref
-
Jefford M, Maraskovsky E, Cebon J, Davis ID, The use of dendritic cells in cancer therapy, The Lancet Oncology, 2, 6, 2001. Crossref
-
Keasey Nikki, Herse Zachary, Chang Stella, Liggitt Denny H., Fairman Jeffery, Lay Marla, Claxton David F., A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects, Cancer Biology & Therapy, 10, 6, 2010. Crossref
-
Kim Hee-Je, Kim Tai-Gyu, Cho Hyun-Il, Han Hoon, Min Woo-Sung, Kima Chun-Choo, The Clinical Implications of Mixed Lymphocyte Reaction with Leukemic Cells, International Journal of Hematology, 76, 4, 2002. Crossref
-
Feller Stephan M., Tuchscherer Gabriele, Voss Jan, High Affinity Molecules Disrupting GRB2 Protein Complexes as a Therapeutic Strategy for Chronic Myelogenous Leukaemia, Leukemia & Lymphoma, 44, 3, 2003. Crossref
-
Liu Aichun, Takahashi Masuhiro, Narita Miwako, Zheng Zhiyin, Kanazawa Naoko, Abe Takashi, Nikkuni Kohji, Furukawa Tatsuo, Toba Ken, Fuse Ichiro, Aizawa Yoshifusa, Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment, Journal of Immunological Methods, 261, 1-2, 2002. Crossref
-
Han P., Story C., McDonald T., Mrozik K., Snell L., Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells, Cytotherapy, 4, 2, 2002. Crossref
-
Park Hae-Young, Park Ji-Yeon, Kim Ja-Woong, Lee Min-Jung, Jang Min-Jung, Lee Sun-Young, Baek Dae-Won, Park Yeong-Min, Lee Sang-Wha, Yoon Sik, Bae Yoe-Sik, Kwak Jong-Young, Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line, International Immunopharmacology, 4, 13, 2004. Crossref
-
Rousseau R, Bollard C, Heslop H, Apport des biothérapies anticancéreuses dans le traitement des leucémies de l’enfant, Archives de Pédiatrie, 9, 3, 2002. Crossref
-
Gong Jianlin, Koido Shigeo, Kato Yoko, Tanaka Yasuhiro, Chen Dongshu, Jonas Anna, Galinsky Ilene, DeAngelo Daniel, Avigan David, Kufe Donald, Stone Richard, Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts, Leukemia Research, 28, 12, 2004. Crossref
-
Heslop Helen E, Rousseau Raphaël F, Bollard Catherine M, Gene therapy for paediatric leukaemia, Expert Opinion on Biological Therapy, 1, 4, 2001. Crossref
-
Véran Julie, Mohty Mohamad, Gaugler Béatrice, Chiavaroli Carlo, Olive Daniel, OM-197-MP-AC adjuvant properties: the in vitro maturation of normal and leukemic dendritic cells in a serum-free culture model, Immunobiology, 209, 1-2, 2004. Crossref
-
Panoskaltsis Nicki, Belanger Todd J, Liesveld Jane L, Abboud Camille N, Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture, Leukemia Research, 26, 2, 2002. Crossref
-
Rooney C. M., Aguilar L. K., Huls M. H., Brenner M. K., Heslop H. E., Adoptive Immunotherapy of EBV-Associated Malignancies with EBV-Specific Cytotoxic T-Cell Lines, in Epstein-Barr Virus and Human Cancer, 258, 2001. Crossref
-
Choudhury A., Liang J.C., Thomas E.K., Flores-Romo L., Xie Q.S., Agusala K., Sutaria S., Sinha I., Champlin R.E., Claxton D.F., Dendritic Cells Derived In Vitro From Acute Myelogenous Leukemia Cells Stimulate Autologous, Antileukemic T-Cell Responses, Blood, 93, 3, 1999. Crossref
-
Choudhury A., Liang J.C., Thomas E.K., Flores-Romo L., Xie Q.S., Agusala K., Sutaria S., Sinha I., Champlin R.E., Claxton D.F., Dendritic Cells Derived In Vitro From Acute Myelogenous Leukemia Cells Stimulate Autologous, Antileukemic T-Cell Responses, Blood, 93, 3, 1999. Crossref
-
Lindner Inna, Cejas Pedro J., Carlson Louise M., Torruellas Julie, Plano Gregory V., Lee Kelvin P., Signal Transduction in DC Differentiation: Winged Messengers and Achilles’ Heel, in Crossroads between Innate and Adaptive Immunity, 590, 2007. Crossref
-
Rooney Cliona M., Huls M. Helen, Rochester Richard A., Brenner Malcolm K., Heslop Helen E., Adoptive Transfer of Polyclonal, EBV-Specific Cytotoxic T-Cell Lines for the Prevention and Treatment of EBV-Associated Malignancies, in Cell Therapy, 2000. Crossref
-
KöHler T., Plettig R., Wetzstein W., Ehninger G., BornhäUser M., Dendritic Cells Generated out of Blasts from Patients with Acute Leukemia, in Acute Leukemias VIII, 40, 2001. Crossref
-
Lindner Inna, Kharfan-Dabaja Mohamed A., Ayala Ernesto, Kolonias Despina, Carlson Louise M., Beazer-Barclay Yasmin, Scherf Uwe, Hnatyszyn James H., Lee Kelvin P., Induced Dendritic Cell Differentiation of Chronic Myeloid Leukemia Blasts Is Associated with Down-Regulation of BCR-ABL, The Journal of Immunology, 171, 4, 2003. Crossref
-
Köhler T., Plettig R., Wetzstein W., Schmitz M., Ritter M., Mohr B., Schaekel U., Ehninger G., Bornhäuser M., Cytokine‐Driven Differentiation of Blasts from Patients with Acute Myelogenous and Lymphoblastic Leukemia into Dendritic Cells, STEM CELLS, 18, 2, 2000. Crossref
-
Boyer MW, Waller EK, Bray RA, Unangst T, Johnson TS, Phillips C, Jurickova I, Winton EF, Yeager AM, Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells, Leukemia, 14, 3, 2000. Crossref
-
Woiciechowsky A, Regn S, Kolb H-J, Roskrow M, Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia, Leukemia, 15, 2, 2001. Crossref
-
Claxton D, Choudhury A, Potential for therapy with AML-derived dendritic cells, Leukemia, 15, 4, 2001. Crossref
-
Moldenhauer Anja, Moore Malcolm A.S., Schmidt Kerstin, Kiesewetter Holger, Salama Abdulgabar, Differences in the transmigration of different dendritic cells, Experimental Hematology, 34, 6, 2006. Crossref